Neuropilin-1 and heparan sulfate proteoglycans cooperate in cellular uptake of nanoparticles functionalized by cationic cell-penetrating peptides
暂无分享,去创建一个
[1] C. Perou,et al. "Synchronized" endocytosis and intracellular sorting in alveolar macrophages: the early sorting endosome is a transient organelle , 1995, The Journal of cell biology.
[2] M. Tessier-Lavigne,et al. Neuropilin Is a Receptor for the Axonal Chemorepellent Semaphorin III , 1997, Cell.
[3] Priscille Brodin,et al. A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.
[4] G. Camussi,et al. HIV-1 Tat Protein Stimulates In Vivo Vascular Permeability and Lymphomononuclear Cell Recruitment , 2001, The Journal of Immunology.
[5] M. Giacca,et al. Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans* , 2001, The Journal of Biological Chemistry.
[6] Kurt Ballmer-Hofer,et al. Antennapedia and HIV Transactivator of Transcription (TAT) “Protein Transduction Domains” Promote Endocytosis of High Molecular Weight Cargo upon Binding to Cell Surface Glycosaminoglycans* , 2003, Journal of Biological Chemistry.
[7] M. Johansson,et al. Cell surface adherence and endocytosis of protein transduction domains. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[8] Steven F Dowdy,et al. Cationic TAT peptide transduction domain enters cells by macropinocytosis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[9] M. Hori,et al. Glycosaminoglycan modification of neuropilin‐1 modulates VEGFR2 signaling , 2006, The EMBO journal.
[10] L. Ellis. The role of neuropilins in cancer , 2006, Molecular Cancer Therapeutics.
[11] S. Dowdy,et al. TAT transduction: the molecular mechanism and therapeutic prospects. , 2007, Trends in molecular medicine.
[12] A. Marcus,et al. Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. , 2007, Journal of the American Chemical Society.
[13] H. Bellamy,et al. Structural basis for ligand and heparin binding to neuropilin B domains , 2007, Proceedings of the National Academy of Sciences.
[14] D. Mukhopadhyay,et al. Vascular Endothelial Growth Factor and Semaphorin Induce Neuropilin-1 Endocytosis via Separate Pathways , 2008, Circulation research.
[15] D. Cheresh,et al. Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. , 2008, Blood.
[16] E. Ruoslahti,et al. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration , 2009, Proceedings of the National Academy of Sciences.
[17] Erkki Ruoslahti,et al. Tissue-penetrating delivery of compounds and nanoparticles into tumors. , 2009, Cancer cell.
[18] M. Morris,et al. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics , 2009, British journal of pharmacology.
[19] T. Ideker,et al. Functional genomic screen for modulators of ciliogenesis and cilium length , 2010, Nature.
[20] Erkki Ruoslahti,et al. Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs , 2010, Science.
[21] Triantafyllos Stylianopoulos,et al. Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. , 2011, Annual review of chemical and biomolecular engineering.
[22] Astrid Gräslund,et al. Mechanisms of Cellular Uptake of Cell-Penetrating Peptides , 2011, Journal of biophysics.
[23] Tokuko Haraguchi,et al. Transient focal membrane deformation induced by arginine-rich peptides leads to their direct penetration into cells. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[24] C. V. Vander Kooi,et al. Effect of C-terminal sequence on competitive semaphorin binding to neuropilin-1. , 2013, Journal of molecular biology.
[25] R. Nussinov,et al. Sequence dependence of C-end rule peptides in binding and activation of neuropilin-1 receptor. , 2013, Journal of structural biology.
[26] Erkki Ruoslahti,et al. Tumor-Penetrating Peptides , 2013, Front. Oncol..
[27] Erkki Ruoslahti,et al. Tumor-Penetrating iRGD Peptide Inhibits Metastasis , 2014, Molecular Cancer Therapeutics.
[28] Xiaoyang Xu,et al. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.
[29] Erkki Ruoslahti,et al. Etchable plasmonic nanoparticle probes to image and quantify cellular internalization , 2014, Nature materials.
[30] Erkki Ruoslahti,et al. An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability , 2014, Nature Communications.
[31] S. Kizaka-Kondoh,et al. Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[32] M. Nugent,et al. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity* , 2015, The Journal of Biological Chemistry.